Karyopharm Therapeutics Inc. ($KPTI)
Poulton Stuart โ EVP, Chief Development Officer
Shares
5,101
Price
$9.41
Total Value
$47,997.86
Nearby Earnings
Feb 18, 2026
EPS:Est: -2.26
Revenue:Est: $33.16M
Transaction Details
| Insider | Poulton Stuart |
|---|---|
| Title | EVP, Chief Development Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 5,101 |
| Price per Share | $9.41 |
| Total Value | $47,997.86 |
| Shares Owned After | 94,328 |
| Derivative | No |
| Accession Number | 0001942597-26-000003 |
| Document | View SEC Filing |